| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |